NasdaqCM - Nasdaq Real Time Price USD

China SXT Pharmaceuticals, Inc. (SXTC)

2.0400

+0.0900

+(4.62%)

At close: June 12 at 4:00:00 PM EDT

2.0000

-0.04

(-1.96%)

After hours: June 12 at 7:57:14 PM EDT

China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency

TAIZHOU, China, March 17, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) (the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that the Company received a written notification (the “Compliance

GlobeNewswire 2 months ago

SXTC
+4.62%
China SXT Pharmaceuticals, Inc. Announces Share Consolidation

TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that it will effect a share consolidation of its ordinary

GlobeNewswire 3 months ago

SXTC
+4.62%
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

Jiangsu, China, , Oct. 07, 2024 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC) announced today that on October 3, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum

GlobeNewswire 8 months ago

SXTC
+4.62%

Performance Overview

Return	SXTC	S&P 500 (^GSPC)
YTD	+301.57%	+2.78%
1-Year	+80.53%	+11.51%
3-Year	-95.75%	+54.97%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

Performance Overview